Rheumatology International

, Volume 35, Issue 6, pp 953–961 | Cite as

Meta-analysis of associations between functional HLA-G polymorphisms and susceptibility to systemic lupus erythematosus and rheumatoid arthritis

Review Article - Genes and Disease

Abstract

The aim of this study was to determine whether the functional HLA-G 14 bp insertion (I)/deletion (D) and +3142 G/C polymorphisms are associated with susceptibility to systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). A meta-analysis was conducted on the associations between the HLA-G 14 bp I/D, and +3142 G/C polymorphisms and SLE or RA using; (1) allele contrast, (2) the recessive model, (3) the dominant model, and (4) additive model. A total of 14 comparison studies from 11 articles met our inclusion criteria, comprising eight on SLE (1,284 patients and 1,885 controls) and four on RA (820 patients and 772 controls), and three studies investigated response to methotrexate (MTX) in RA according to the HLA-G 14 bp I/D polymorphisms (249 responders and 205 nonresponders). Meta-analysis revealed an association between the II + ID genotype of the HLA-G 14 bp I/D polymorphism in overall group (OR = 1.205, 95 % CI = 1.036–1.403, P = 0.016). Ethnicity-specific meta-analysis showed no association between the II + ID genotype and SLE in the South American, European, and Asian population. Meta-analysis revealed a significant association between SLE and the HLA-G +3142 G allele in all study subjects (OR = 1.367, 95 % CI = 1.158–1.613, P = 2.2 × 10−5) and in the South American group (OR = 1.531, 95 % CI = 1.242–1.888, P = 6.7 × 10−5). However, no association between HLA-G 14 bp I/D, and +3142 G/C polymorphisms and RA was found (OR for HLA-G I allele = 1.013, 95 % CI = 0.879–1.167, P = 0.859; OR for +3142 G allele = 0.980, 95 % CI = 0.742–1.294, P = 0.888). Furthermore, HLA-G 14 bp I/D polymorphism was not found to be associated with response to MTX in RA. This meta-analysis demonstrates that the HLA-G 14 bp I/D polymorphism is associated with susceptibility to SLE, and HLA-G +3142 G/C polymorphisms are associated with susceptibility to SLE in South Americans.

Keywords

Systemic lupus erythematosus Rheumatoid arthritis HLA-G Polymorphism Meta-analysis 

References

  1. 1.
    Lee YH, Nath SK (2005) Systemic lupus erythematosus susceptibility loci defined by genome scan meta-analysis. Hum Genet 118(3–4):434–443CrossRefPubMedGoogle Scholar
  2. 2.
    Choi SJ, Rho YH, Ji JD, Song GG, Lee YH (2006) Genome scan meta-analysis of rheumatoid arthritis. Rheumatology (Oxford) 45(2):166–170CrossRefGoogle Scholar
  3. 3.
    Dorling A, Monk NJ, Lechler RI (2000) HLA-G inhibits the transendothelial migration of human NK cells. Eur J Immunol 30(2):586–593CrossRefPubMedGoogle Scholar
  4. 4.
    Bainbridge DR, Ellis SA, Sargent IL (2000) HLA-G suppresses proliferation of CD4(+) T-lymphocytes. J Reprod Immunol 48(1):17–26CrossRefPubMedGoogle Scholar
  5. 5.
    Rousseau P, Le Discorde M, Mouillot G, Marcou C, Carosella ED, Moreau P (2003) The 14 bp deletion-insertion polymorphism in the 3′ UT region of the HLA-G gene influences HLA-G mRNA stability. Hum Immunol 64(11):1005–1010CrossRefPubMedGoogle Scholar
  6. 6.
    Tan Z, Randall G, Fan J, Camoretti-Mercado B, Brockman-Schneider R, Pan L et al (2007) Allele-specific targeting of microRNAs to HLA-G and risk of asthma. Am J Hum Genet 81(4):829–834CrossRefPubMedCentralPubMedGoogle Scholar
  7. 7.
    Chen T, Lin J, Jin S, Ma S, Yu L, Huang K et al (2014) Association of three polymorphisms in the 3′ untranslated region of the HLA-G gene with systemic lupus erythematosus in a population from Yunnan. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 31(2):228–232PubMedGoogle Scholar
  8. 8.
    Lucena-Silva N, de Souza VS, Gomes RG, Fantinatti A, Muniz YC, de Albuquerque RS et al (2013) HLA-G 3′ untranslated region polymorphisms are associated with systemic lupus erythematosus in 2 Brazilian populations. J Rheumatol 40(7):1104–1113CrossRefPubMedGoogle Scholar
  9. 9.
    Consiglio CR, Veit TD, Monticielo OA, Mucenic T, Xavier RM, Brenol JC et al (2011) Association of the HLA-G gene +3142C > G polymorphism with systemic lupus erythematosus. Tissue Antigens 77(6):540–545CrossRefPubMedGoogle Scholar
  10. 10.
    Wu FX, Wu LJ, Luo XY, Tang Z, Yang MH, Xie CM et al (2009) Lack of association between HLA-G 14-bp polymorphism and systemic lupus erythematosus in a Han Chinese population. Lupus 18(14):1259–1266CrossRefPubMedGoogle Scholar
  11. 11.
    Veit TD, Cordero EA, Mucenic T, Monticielo OA, Brenol JC, Xavier RM et al (2009) Association of the HLA-G 14 bp polymorphism with systemic lupus erythematosus. Lupus 18(5):424–430CrossRefPubMedGoogle Scholar
  12. 12.
    Rizzo R, Hviid TV, Govoni M, Padovan M, Rubini M, Melchiorri L et al (2008) HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus. Tissue Antigens 71(6):520–529CrossRefPubMedGoogle Scholar
  13. 13.
    Catamo E, Addobbati C, Segat L, Sotero Fragoso T, Domingues Barbosa A, Tavares Dantas A et al (2014) HLA-G gene polymorphisms associated with susceptibility to rheumatoid arthritis disease and its severity in Brazilian patients. Tissue Antigens 84(3):308–315Google Scholar
  14. 14.
    Veit TD, de Lima CP, Cavalheiro LC, Callegari-Jacques SM, Brenol CV, Brenol JC et al (2014) HLA-G +3142 polymorphism as a susceptibility marker in two rheumatoid arthritis populations in Brazil. Tissue Antigens 83(4):260–266CrossRefPubMedGoogle Scholar
  15. 15.
    Rizzo R, Rubini M, Govoni M, Padovan M, Melchiorri L, Stignani M et al (2006) HLA-G 14-bp polymorphism regulates the methotrexate response in rheumatoid arthritis. Pharmacogenet Genomics 16(9):615–623CrossRefPubMedGoogle Scholar
  16. 16.
    Stamp LK, O’Donnell JL, Chapman PT, Barclay ML, Kennedy MA, Frampton CM et al (2009) Lack of association between HLA-G 14 bp insertion/deletion polymorphism and response to long-term therapy with methotrexate response in rheumatoid arthritis. Ann Rheum Dis 68(1):154–155CrossRefPubMedGoogle Scholar
  17. 17.
    Kooloos WM, Wessels JA, van der Straaten T, Allaart CF, Huizinga TW, Guchelaar HJ (2010) Functional polymorphisms and methotrexate treatment outcome in recent-onset rheumatoid arthritis. Pharmacogenomics 11(2):163–175CrossRefPubMedGoogle Scholar
  18. 18.
    Lee YH, Rho YH, Choi SJ, Ji JD, Song GG (2007) PADI4 polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis. Rheumatol Int 27(9):827–833CrossRefPubMedGoogle Scholar
  19. 19.
    Lee YH, Bae SC, Choi SJ, Ji JD, Song GG (2011) Associations between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. Mol Biol Rep 38(6):3643–3651CrossRefPubMedGoogle Scholar
  20. 20.
    Lee YH, Bae SC, Choi SJ, Ji JD, Song GG (2012) The association between the PTPN22 C1858T polymorphism and rheumatoid arthritis: a meta-analysis update. Mol Biol Rep 39(4):3453–3460CrossRefPubMedGoogle Scholar
  21. 21.
    Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558CrossRefPubMedGoogle Scholar
  22. 22.
    Egger M, Smith GD, Phillips AN (1997) Meta-analysis: principles and procedures. BMJ 315(7121):1533–1537CrossRefPubMedCentralPubMedGoogle Scholar
  23. 23.
    DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188CrossRefPubMedGoogle Scholar
  24. 24.
    Faul F, Erdfelder E, Buchner A, Lang AG (2009) Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods 41(4):1149–1160CrossRefPubMedGoogle Scholar
  25. 25.
    Egger M, Smith GD, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634CrossRefPubMedCentralPubMedGoogle Scholar
  26. 26.
    Carosella ED, Moreau P, Aractingi S, Rouas-Freiss N (2001) HLA-G: a shield against inflammatory aggression. Trends Immunol 22(10):553–555CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Division of Rheumatology, Department of Internal Medicine, Korea University Anam HospitalKorea University College of MedicineSeoulKorea
  2. 2.Division of Rheumatology, Department of Internal Medicine, The Hospital for Rheumatic DiseasesHanyang University Medical CenterSeoulKorea

Personalised recommendations